九安医疗发预增，预计2025年度归母净利润20.2亿元至23.5亿元，增长21.05%至40.83%

Core Viewpoint - Jiuan Medical (002432.SZ) forecasts a net profit attributable to shareholders of between 2.02 billion yuan and 2.35 billion yuan for the fiscal year 2025, representing a year-on-year growth of 21.05% to 40.83% [1] Financial Performance - The company expects a net profit after deducting non-recurring gains and losses to be between 2.07 billion yuan and 2.4 billion yuan, indicating a year-on-year increase of 23.18% to 42.81% [1] - The growth in net profit compared to the same period last year is primarily attributed to the strong performance of asset management business in major asset allocation [1] Business Strategy - The company is committed to achieving asset preservation and appreciation while continuously enhancing its risk resistance capabilities [1] - Demand for the company's reagent kits, which serve as regular home screening tools for respiratory viruses, as well as home medical health electronic products, remains stable [1]